echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Kelun Pharmaceutical Omeprazole Sodium for Injection Passed the Consistency Evaluation of Generic Drugs

    Kelun Pharmaceutical Omeprazole Sodium for Injection Passed the Consistency Evaluation of Generic Drugs

    • Last Update: 2021-07-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On May 21, Kelun Pharmaceutical issued an announcement stating that its subsidiary Hunan Kelun Pharmaceutical Co.


    It is reported that the drug is mainly used for ulcer bleeding, acute gastric mucosal injury, prevention of severe diseases (such as cerebral hemorrhage, severe trauma, etc.


    Relevant data shows that Omeprazole Sodium for Injection is a category B product of the National Medical Insurance in 2020 and a product of the 2018 National Essential Drug List.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.